| __timestamp | PTC Therapeutics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 381287000 |
| Thursday, January 1, 2015 | 82080000 | 452612000 |
| Friday, January 1, 2016 | 97130000 | 316800000 |
| Sunday, January 1, 2017 | 121271000 | 330100000 |
| Monday, January 1, 2018 | 153548000 | 265800000 |
| Tuesday, January 1, 2019 | 202541000 | 336200000 |
| Wednesday, January 1, 2020 | 245164000 | 423900000 |
| Friday, January 1, 2021 | 285773000 | 467000000 |
| Saturday, January 1, 2022 | 325998000 | 487000000 |
| Sunday, January 1, 2023 | 332540000 | 477100000 |
Unleashing the power of data
In the competitive landscape of biotechnology, understanding the financial strategies of leading companies is crucial. Over the past decade, United Therapeutics Corporation and PTC Therapeutics, Inc. have demonstrated distinct approaches in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, United Therapeutics consistently allocated a higher percentage of their revenue to SG&A, peaking at approximately 48% in 2022. In contrast, PTC Therapeutics showed a steady increase, with their SG&A expenses growing by over 640% during the same period. This divergence highlights United Therapeutics' focus on maintaining robust administrative operations, while PTC Therapeutics appears to be ramping up its market presence. As the biotech sector evolves, these financial strategies will play a pivotal role in shaping the future trajectories of these companies.
Gilead Sciences, Inc. vs United Therapeutics Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
United Therapeutics Corporation vs Xencor, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
PTC Therapeutics, Inc. vs Merus N.V.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.